… MD; Blanco, Ricardo MD, PhD; Melero-González, Rafael MD; Ibáñez-Rúan, Jesús MD;
Bernal-Vidal, José Antonio MD; Tomero-Muriel, Eva MD; Uriarte-Isacelaya, Esther MD; …

Introduction Antiphospholipid antibodies (aPL) have been associated with organ damage
and certain features in systemic lupus erythematosus(SLE) patients. Our aim was to …

Objective To investigate the influence of COVID-19 vaccination on disease activity in
rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients under targeted therapies. Patients …

Introduction One of the most important aims in the management of systemic lupus erythematosus
(SLE) is to avoid or delay the accumulation of organ damage. The first five years after …

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with
refractory Takayasu’s arteritis (TAK) in clinical practice. Methods: A multicenter study of …

Introduction Obstetric complications are more common in women with systemic lupus
erythematosus (SLE) than in the general population. Objective To assess pregnancy outcomes in …

Management of systemic autoimmune diseases is challenging for physicians in their clinical
practice. Although not common, they affect thousands of patients in Spain. The family doctor …

Objective Adult‐onset Still's disease (AOSD) is frequently refractory to standard therapy.
Tocilizumab (TCZ) has demonstrated efficacy in single cases and in small series of patients with …

Objectives To analyze the prevalence, incidence, survival and contribution on mortality of
major central nervous system (CNS) involvement in systemic lupus erythematosus (SLE). …

Objective. Non-infectious aortitis is often refractory to standard immunosuppressive therapy.
Since IL-6 has been implicated in the pathogenesis of aortitis, we assessed the efficacy of …